share_log

4: Statement of changes in beneficial ownership of securities-Director McMullen Michael R.

4: Statement of changes in beneficial ownership of securities-Director McMullen Michael R.

4：持股变动声明-董事 McMullen Michael R.
美股sec公告 ·  07/02 17:37
Moomoo AI 已提取核心信息
Michael R. McMullen, associated with Bristol-Myers Squibb Co. [BMY], was involved in a transaction on 07/01/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. As such, the impact of this event on McMullen's holdings and the overall market position of Bristol-Myers Squibb remains unclear.
Michael R. McMullen, associated with Bristol-Myers Squibb Co. [BMY], was involved in a transaction on 07/01/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. As such, the impact of this event on McMullen's holdings and the overall market position of Bristol-Myers Squibb remains unclear.
与施贵宝公司[BMY]有关的Michael R. McMullen在2024年07月01日进行了一项交易。公告未披露该交易的具体细节，包括操作类型、状态币、涉及的股份数量、股份性质、交易价格和发帖后持股情况。因此，这一事件对于McMullen的持股和施贵宝的整体市场地位的影响仍不清楚。
与施贵宝公司[BMY]有关的Michael R. McMullen在2024年07月01日进行了一项交易。公告未披露该交易的具体细节，包括操作类型、状态币、涉及的股份数量、股份性质、交易价格和发帖后持股情况。因此，这一事件对于McMullen的持股和施贵宝的整体市场地位的影响仍不清楚。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息